Author:
Moore Gaea S.,Allshouse Amanda A.,Winn Virginia D.,Galan Henry L.,Heyborne Kent D.
Subject
Obstetrics and Gynaecology,Internal Medicine
Reference27 articles.
1. Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. Evidence and Information for Policy (EIP), World Health Organization, Geneva, July 2003.
2. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004;Wallis;Am J Hypertens,2008
3. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders;Autiero;J Thromb Haemost,2003
4. A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia;Kusanovic;J Maternal Fetal Neonatal Med,2009
5. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献